Chitosan-drug conjugate microspheres: Preparation and drug release properties of microspheres composed of the conjugate of 2′- or 3′-(4-carboxy-butyryl)-5-fluorouridine with chitosan

Drug Development and Industrial Pharmacy

Volumn 22, Issue 5, 1996, Pages 457-463

  Onishi, Hiraku ^a   Shimoda, Junko ^a   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; FLUOROURACIL DERIVATIVE; FLUOROURIDINE; MICROSPHERE;

ARTICLE; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0029890713     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049609069355     Document Type: Article

References (24)

1. T. Sannan, in Abstract of Papers, 13th Conference on Pharmaceutical Technology (The Academy of Pharmaceutical Sciences and Technology, Jpn.), Shirakabako, July 1988, p. 104.
2. J. F. Prudden, P. Miegel, P. Hanson, L. Friedrich, and L. Balassa, Am. J. Surg., 119, 560 (1970).
3. R. C. Davies, A. Neuberger, and B. M. Wilson, Biochim. Biophys. Acta, 178, 294 (1969).
4. K. Amano and E. Ito, Eur. J. Biochem., 85, 97 (1978).
5. S. H. Pungburn, P. V. Trescony, and J. Heller, Biomaterials, 3, 105 (1982).
6. C. Yomota, T. Komuro, and T. Kimura, Yakugaku Zasshi, 110, 442 (1990).
7. F. Nakamura, H. Onishi, Y. Machida, and T. Nagai, Yakuzaigaku, 52, 59 (1992).
8. K. Inouye, Y. Machida, and T. Nagai, Drug Design Deliv., 1, 297 (1987).
9. K. Inouye, Y. Machida, T. Sannan, and T. Nagai, Drug Design Deliv., 2, 165 (1988).
10. K. Inouye, Y. Machida, T. Sannan, and T. Nagai, Drug Design Deliv., 2, 55 (1989).
11. Y. P. Li, Y. Machida, T. Sannan, and T. Nagai, STP Pharma Sci., 1, 363 (1991).
12. T. Yoshino, Y. Machida, H. Onishi, and T. Nagai, STP Pharma Sci., in press.
13. T. Ouchi, T. Banba, T. Matsumoto, S. Suzuki, and M. Suzuki, J. Bioact. Comp. Polym., 4, 362 (1989).
14. Y. D. Sanzgiri, C. D. Blanton, Jr., and J. M. Gallo, Pharm. Res., 7, 418 (1990).
15. H. Ichikawa, H. Onishi, T. Takahata, Y. Machida, and T. Nagai, Drug Design Discovery, 10, 343, (1993).
16. H. Ichikawa, H. Onishi, M. Sato, Y. Machida, and T. Nagai, Yakuzaigaku, 55, 59 (1995).
17. H. Onishi, Y. Machida, and T. Nagai, Chem. Pharm. Bull., 43, 340 (1995).
18. K. Sugibayashi, Y. Morimoto, T. Nadai, Y. Kato, A. Hasegawa, and T. Arita, Chem. Pharm. Bull., 27, 204 (1979).
19. M. Kanke, G. H. Simmons, D. L. Weiss, B. A. Bivins, and P. P. Deluca, J. Pharm. Sci., 69, 755 (1980).
20. T. Yoshioka, M. Hashida, S. Muranishi, and H. Sezaki, Int. J. Pharm., 8, 131 (1981).
21. T. Kato, K. Unno, and A. Goto, in Methods in Enzymology (K. J. Widder and R. Green, eds.), Academic Press, Tokyo, 1985, p. 139.
22. T. Kato, R. Nemoto, H. Mori, M. Takahashi, Y. Tamakawa, and M. Harada, J. Am. Med. Assoc., 245, 1123 (1981).
23. M. Minabe, M. Iida, K. Takeuchi, T. Hori, S.-H. Hyon, and Y. Ikada, Drug Delivery System, 6, 201 (1991).
24. H. Onishi, T. Kawaguchi, and T. Nagai, Chem. Pharm. Bull., 35, 3370 (1987).